EMG
ALXA

Ellington Management Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Ellington Management Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-14,617
Closed -$75K – 942
2013
Q3 		$75K Buy
+14,617
New +$68.8K 0.01% 734

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ellington Management Group's ALXA Position: Q4 2013 in Review

Ellington Management Group sold out of Alexza Pharmaceuticals Inc (ALXA) in Q4 2013, closing a stake of 14,617 shares — an estimated $75K sold.

Ellington Management Group first reported a position in ALXA in Q3 2013 and held it in 1 quarter. The position peaked at $75K in Q3 2013. 41 funds tracked by Wall St. Rank hold ALXA as of Q4 2013.

  • Ellington Management Group reported no remaining Alexza Pharmaceuticals Inc position as of Q4 2013 after selling out during the quarter.
  • Ellington Management Group sold 14,617 Alexza Pharmaceuticals Inc shares in Q4 2013, an estimated $75K.
  • Ellington Management Group first reported a position in Alexza Pharmaceuticals Inc in Q3 2013 and held it in 1 quarter.
  • Ellington Management Group's Alexza Pharmaceuticals Inc position peaked at $75K in Q3 2013.
  • 41 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q4 2013.

Based on Ellington Management Group's 13F filing for Q4 2013, filed 14 Feb 2014.